Autoimmune Markers for Non-Invasive Diagnosis of Endometriosis in Women

In: Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry · 2020 · vol. 14(4) , pp. 335–339 · doi:10.1134/s1990750820040083 · W4244351555
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This study identified elevated IgG antibodies to tropomyosin 3, α-enolase, and estradiol in women with endometriosis, demonstrating their potential for non-invasive diagnosis with high sensitivity and specificity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text

This study examined the autoantibody profile in women with external genital endometriosis, using modified enzyme-linked immunosorbent assay methods to measure mainly IgG antibodies against specific targets including endometrial antigens (tropomyosin 3, tropomodulin 3), α-enolase, steroid hormones (estradiol, progesterone), and gonadotropin. In 39 patients with stage III–IV disease, detection rates and IgG levels for antibodies to tropomyosin 3, α-enolase, estradiol, and human chorionic gonadotropin were higher than in 26 healthy controls (p < 0.05). IgG antibodies to tropomyosin 3, α-enolase, and estradiol showed higher diagnostic value individually, and together yielded an AUC of 0.875 with sensitivity and specificity of 83.3%; the main caveat is the relatively small case-control sample size. This paper is centrally about endometriosis — it focuses on autoimmune antibody biomarkers for non-invasive diagnosis of endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is a common estrogen-dependent chronic disease of women of reproductive age; it is associated with dysregulation of the immune response, local inflammatory process and increased autoantibody production. The purpose of this study was to investigate the autoantibody profile in women with endometriosis by means of new modifications of the enzyme-linked immunosorbent assay and to evaluate their diagnostic value. In women with external genital endometriosis stage III–IV (n = 39), a wide range of autoantibodies of mainly class G was detected; these included antibodies to endometrial antigens (tropomyosin 3, tropomodulin 3), the enzyme α-enolase, steroid hormones (estradiol, progesterone) and gonadotropin. Moreover, the detection rate of IgG antibodies to tropomyosin 3, α-enolase, estradiol, and human chorionic gonadotropin and their levels in patients with endometriosis were higher than in healthy women (n = 26) (p < 0.05). IgG antibodies to tropomyosin 3, α-enolase and estradiol were characterized by a higher diagnostic value for endometriosis. When determining the combination of these antibodies, the diagnostic significance increased, the AUC value was 0.875 [0.772–0.978] (p < 0.0001), and sensitivity and specificity reached 83.3%. Thus, autoantibodies to tropomyosin 3, α-enolase and estradiol are promising for inclusion in the panel of biomarkers for non-invasive diagnosis of endometriosis.
Full text 5,056 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Endometriosis is a common estrogen-dependent chronic disease of women of reproductive age; it is associated with dysregulation of the immune response, local inflammatory process and increased autoantibody production. The purpose of this study was to investigate the autoantibody profile in women with endometriosis by means of new modifications of the enzyme-linked immunosorbent assay and to evaluate their diagnostic value. In women with external genital endometriosis stage III–IV (n = 39), a wide range of autoantibodies of mainly class G was detected; these included antibodies to endometrial antigens (tropomyosin 3, tropomodulin 3), the enzyme α-enolase, steroid hormones (estradiol, progesterone) and gonadotropin. Moreover, the detection rate of IgG antibodies to tropomyosin 3, α-enolase, estradiol, and human chorionic gonadotropin and their levels in patients with endometriosis were higher than in healthy women (n = 26) (p < 0.05). IgG antibodies to tropomyosin 3, α-enolase and estradiol were characterized by a higher diagnostic value for endometriosis. When determining the combination of these antibodies, the diagnostic significance increased, the AUC value was 0.875 [0.772–0.978] (p < 0.0001), and sensitivity and specificity reached 83.3%. Thus, autoantibodies to tropomyosin 3, α-enolase and estradiol are promising for inclusion in the panel of biomarkers for non-invasive diagnosis of endometriosis. Similar content being viewed by others

References

Bulun, S.E., Yilmaz, B.D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kohlmeier, A., Yin, P., Milad, M., and Wei, J., Endocrine Reviews, 2019, vol. 40, no. 4, pp. 1048–1079. https://doi.org/10.1210/er.2018-00242 Zhang, T., De Carolis, C., Wai Man, G.C., and Wang, C.C., Autoimmunity Reviews, 2018, vol. 17, pp. 945–955. https://doi.org/10.1016/j.autrev.2018.03.017 Lagana, A.S., Garzon, S., Gotte, M., Vigano, P., Franchi, M., Ghezzi, F., and Martin, D.C., Int. J. Mol. Sci., 2019, vol. 20, 5616. https://doi.org/10.3390/ijms20225615 Tosti, C., Pinzauti, S., Santulli, P., Chapron, C., and Petraglia, F., Reprod. Sciences, 2015, vol. 22, no. 9, pp. 1053–1059. https://doi.org/10.1177/1933719115592713 Korotkova, T.D., Adamyan, L.V., Stepanyan, A.A., Krechetova, L.V., and Vanko, L.V., Problemy Reproduktsii, 2018, vol. 24, no. 6, pp. 22–31. https://doi.org/10.17116/repro20182406122 Dorien, F.O., Flores, I., Waelkens, E., and D’Hooghe, T., Best Practice Research Clinical Obstetrics Gynaecology, 2018, vol. 50, pp. 72–83. Nisenblat, V., Bossuyt, P.M.M., Shaikh, R., Farquhar, C., Jordan, V., Scheffers, C.S., Mol, B.W.J., Johnson, N., and Hull, M.L., Cochrane Database Syst Rev., 2016, vol. 5, CD012179. https://doi.org/10.1002/14651858.CD012179 Gajbhiye, R., Bendigeri, T., Ghuge, A., Bhusane, K., Begum, S., Warty, N., Sawant, R., Padte, K., Humane, A., Dasmahapatra, P., Chauhan, A. and Khan, S., Reprod. Sciences, 2017, vol. 24, no. 3, pp. 413–420.https://doi.org/10.1177/1933719116657190 Nabeta, M., Abe, Y., Kagawa, L., Haraguchi, R., Kito, K., Ueda, N., Sugita, A., Yokoyama, M., Kusanagi, Y., and Ito, M., Proteomics Clin. Appl., 2009, vol. 3, pp. 1201–1210. https://doi.org/10.1002/prca.200900055 Nabeta, M., Abe, Y., Takaoka, Y., Kusanagi, Y., and Ito, M., J. Reprod. Immunol., 2011, vol. 91, pp. 48–55. https://doi.org/10.1016/j.jri.2011.04.012 Menzhinskaya, I.V., Gladkova, K.A., Sidelnikova, V.M., and Sukhikh, G.T., Immunologiya, 2008, vol. 29, no. 1, pp. 34–37. Menzhinskaya, I.V., Kashentseva, M.M., Vanko, L.V., and Sukhikh, G.T., Immunologiya, 2015, vol. 36, no. 1, pp. 30–35. Cappello, P., Principe, M., Bulfamante, S., and Novelli, F., Front. Biosci., 2017, vol. 22, pp. 944–959. ACKNOWLEDGMENTS The authors are grateful to the Laboratory for the Collection and Storage of Biological Material of Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology (Head, S.M. Mullabaeva). Funding The work was performed within the State Assignment “Development of Approaches for Non-invasive Diagnostics of Endometriosis based on Omics Technologies,” registration no AAAA-A19-119021490132-9. Author information Authors and Affiliations Corresponding author Ethics declarations COMPLIANCE WITH ETHICAL STANDARDS The study protocol was approved by the Commission on Ethics of Biomedical Research (Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology). Before inclusion in the study, all participants gave written informed consent. CONFLICT OF INTERESTS The authors declare that they have no conflict of intere-st. Additional information Translated by A. Medvedev Rights and permissions About this article Cite this article Menzhinskaya, I.V., Melkumyan, A.G., Pavlovich, S.V. et al. Autoimmune Markers for Non-Invasive Diagnosis of Endometriosis in Women. Biochem. Moscow Suppl. Ser. B 14, 335–339 (2020). https://doi.org/10.1134/S1990750820040083 Received: Revised: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1134/S1990750820040083

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (11)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK